UA-118272889-1 1739406299646766 A Blood Test to Screen For Colorectal Cancer? Epigenomics Has It - WE Have Cancer

bonus

Published on:

5th Nov 2017

A Blood Test to Screen For Colorectal Cancer? Epigenomics Has It

Noel Doheny, CEO of Epigenomics, spoke with me during Tomorrow Can’t Wait, the 2017 Colorectal Cancer Alliance conference. Epigenomics has developed the first FDA and PMA approved liquid biopsy test to screen for colorectal cancer.

The post A Blood Test to Screen For Colorectal Cancer? Epigenomics Has It appeared first on The Colon Cancer Podcast.

Next Episode All Episodes Previous Episode

Listen for free

RSS Feed Apple Podcasts Spotify

About the Podcast

WE Have Cancer

Providing information, inspiration and hope to those touched by cancer.

Each year more than 12 million people will hear the devastating words "you have cancer."

In each episode of WE Have Cancer we share the stories of patients, survivors, caregivers and medical professionals as a way to provide information, inspiration and hope to those touched by cancer.

The host, Lee Silverstein, is a survivor of a rare form of pediatric kidney cancer and has been battling stage 4 colon cancer since 2011.

About your host

Lee & Linda Silverstein

In 2011, just four months after they began dating, Lee was diagnosed with Stage 2 colon cancer. A year and a half later, 17 days after their honeymoon, they learned that Lee’s cancer had spread to his liver; he was now Stage 4. Through numerous surgeries, chemotherapy infusions and assorted other treatments, Linda has been by his side. Despite cancer, Lee and Linda say unequivocally these have been the best years of their lives.

In 2015 Lee launched this podcast as a way to provide information, inspiration and hope to those affected by cancer.

Lee and Linda live in Florida with their Westie Terrier, Fergie.

The WE Have Cancer podcast is supported by The Colon Cancer Coalition - https://coloncancercoalition.org